|
Changes in DNA hydroxymethylation for the detection of multiple cancers in plasma cell-free DNA. |
| |
|
No Relationships to Disclose |
| |
|
Patents, Royalties, Other Intellectual Property - Bluestar Genomics (Inst) |
| |
|
Stock and Other Ownership Interests - LabCorp |
| |
|
No Relationships to Disclose |
| |
|
|
Consulting or Advisory Role - Bluestar Genomics |
Patents, Royalties, Other Intellectual Property - Genentech |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
Travel, Accommodations, Expenses - F1 Oncology |
| |
|
Employment - Genomic Health |
Stock and Other Ownership Interests - Genomic Health |
Patents, Royalties, Other Intellectual Property - Bluestar Genomics (Inst) |
| |
|
Employment - Bluestar Genomics; Genomic Health |
Stock and Other Ownership Interests - Bluestar Genomics; Genome Medical; Genomic Health; InVitae |
Patents, Royalties, Other Intellectual Property - Genomic Health (Inst) |
Travel, Accommodations, Expenses - Bluestar genomics; Genomic Health |
| |
|
Stock and Other Ownership Interests - Gilead Sciences |
| |
|
No Relationships to Disclose |
| |
|
Employment - Bluestar Genomics |
Leadership - Bluestar Genomics |
Stock and Other Ownership Interests - Bluestar Genomics |
Patents, Royalties, Other Intellectual Property - Bluestar Genomics |